期刊文献+

心力衰竭与“肥胖悖论”:真命题还是假命题 被引量:1

Heart failure and the'Obesity Paradox'——true or false?
原文传递
导出
摘要 肥胖已经成为日益严重的社会公共健康问题.既往研究发现,肥胖是心血管疾病发生的独立危险因素之一,但在罹患心血管疾病人群中,肥胖患者的预后较无肥胖患者好.肥胖在健康与疾病的不同背景下,发挥了截然相反的作用,这种现象被称为'肥胖悖论'.本文以心力衰竭作为疾病背景,在梳理既往研究和文献基础上,对这一现象进行讨论. Obesity has become increasingly serious social public health problems now.Previous studies found that obesity is one of the independent risk factors for cardiovascular disease,but the prognosis of obese patients is better than that of non-obese patients.Obesity plays an opposite role in different backgrounds of health and disease,which is called'obesity paradox'.This article will take heart failure as disease background to discuss the phenomenon on the basis of previous studies and literature.
作者 薛彦博 马琼 马爱群 Xue Yanbo;Ma Qiong;Ma Aiqun(Department of Cardiovascular Medicine,First Affiliated Hospital of Xi'an Jiaotong University,Shaanxi Key Laboratory of Molecular Cardiology,Key Laboratory of Environment and Genes Related to Diseases,Ministry of Education,Xi'an 710061,China)
出处 《中华心力衰竭和心肌病杂志(中英文)》 2019年第2期65-68,共4页 Chinese Journal of Heart Failure and Cardiomyopathy
基金 国家科技惠民计划(2012GS610101) 国家重点研发计划(2017YFC1308302).
关键词 心力衰竭 肥胖悖论 预后 Heart failure Obesity paradox Prognosis
  • 相关文献

参考文献3

二级参考文献42

  • 1卫生部心血管病防治研究中心.2005年中国心血管病报告.北京:中国大百科全书出版社,2006:1-4.
  • 2Lavie C J, Osman AF, Milani RV, et al. Body composition and prognosis in chronic systolic heart failure: the obesity paradox. Am J Cardiol, 2003, 91:891-894.
  • 3Curtis JP, Selter JG, Wang Y, et al. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med, 2005, 165:55-61.
  • 4Kalantar-Zadeh K, Block G, Horwich T, et al. Reverse epidemiology of conventional cardiovascular risk factors in patients with ehrortic heart failure. J Am Coll Cardiol, 2004, 43: 1439- 1444.
  • 5Kistorp C, Faber J, Galatius S, et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation, 2005, 112 : 1756-1762.
  • 6Kenchaiah S, Pocock S J, Wang D, et al. Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart Failure : assessment of reduction in mortality and morbidity (CHARM) program. Circulation, 2007, 116 : 627- 636.
  • 7Cicoira M, Maggioni AP, Latini R, et al. Body mass index, prognosis and mode of death in chronic heart failure: results from the Valsartan Heart Failure Trial. Eur J Heart Fail, 2007, 9:397- 402.
  • 8Berry C, Clark AL. Catabolism in chronic heart failure. Eur Heart J, 2000, 21:521-532.
  • 9Anker SD, Ranchhaus M. Insights into the pathogenesis of chronic heart failure: immune activation and cachexia. Curr Opin Cardiol, 1999, 14: 211-216.
  • 10Anker SD, Negassa A, Coats A J, et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet, 2003, 361 : 1077-1083.

共引文献33

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部